Moderna, Inc. Net Income Loss

• Moderna, Inc. showed an increase of +20.8% in Net Income Loss from 2024 to 2025.
• This data is from Moderna, Inc.'s annual report (Form 10-K), filed with the SEC on February 20, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2016 to 2025), Moderna, Inc.'s Net Income Loss has declined by 1,205.2%.
• Historical annual values: Fiscal year 2025: -$2.82 billion | Fiscal year 2024: -$3.56 billion | Fiscal year 2023: -$4.71 billion | Fiscal year 2022: $8.36 billion | Fiscal year 2021: $12.20 billion | Fiscal year 2020: -$747.00 million | Fiscal year 2019: -$514.00 million | Fiscal year 2018: -$384.73 million | Fiscal year 2017: -$255.92 million | Fiscal year 2016: -$216.21 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026